FOI-01905

Thank you for your request for information about the following: 

##Request 

You asked us: 

‘I am requesting the following information on the prescribing of pregabalin and gabapentin in England: 

The total number of unique identified patients receiving prescriptions for pregabalin and equivalent brands in each of the financial years between 2015/2016 and 2023/2024 (or the latest data available). 

The total number of unique identified patients receiving prescriptions for gabapentin and equivalent brands in each of the financial years between 2015/2016 and 2023/2024 (or the latest data available).’ 

The NHS Business Services Authority (NHSBSA) received your request on 2 May 2024.  

We have handled your request under the Freedom of Information Act (FOIA) 2000. 

##Our response 

I can confirm that the NHSBSA holds the information you have requested and a copy of the information and notes explaining it is attached. 

Please read the below notes to ensure correct understanding of the data. 

NHS Prescription Services process prescriptions for Pharmacy Contractors, Appliance Contractors, Dispensing Doctors and Personal Administration with information then used to make payments to pharmacists and appliance contractors in England for prescriptions dispensed in primary care settings (other arrangements are in place for making payments to Dispensing Doctors and Personal Administration). This involves processing over 1 billion prescription items and payments totalling over £9 billion each year. The information gathered from this process is then used to provide information on costs and trends in prescribing in England and Wales to over 25,000 registered NHS and Department of Health and Social Care users. 

##Data Source: ePACT2 

Data in ePACT2 is sourced from the NHSBSA Data Warehouse and is derived from products prescribed on prescriptions and dispensed in the Community. The data captured from prescription processing is used to calculate reimbursement and remuneration. It includes items prescribed in England, Wales, Scotland, Northern Ireland, Guernsey / Alderney, Jersey, and Isle of Man which have been dispensed in the community in England. English prescribing that has been dispensed in Wales, Scotland, Guernsey / Alderney, Jersey, and Isle of Man is also included. 

The Data excludes:  

• Items not dispensed, disallowed and those returned to the contractor for further clarification.  

• Prescriptions prescribed and dispensed in Prisons, Hospitals and Private prescriptions. 

• Items prescribed but not presented for dispensing or not submitted to NHS Prescription Services by the dispenser. 

##Time Period 

Financial Years 2015/2016, 2016/2017, 2017/2018, 2018/2019, 2019/2020, 2020/2021, 2021/2022, 2022/2023 and 2023/2024. 

##Organisation Data 

The data is limited to prescriptions prescribed in England and dispensed in the community. 

##Data 

This dataset is limited to the total number of unique patients prescribed BNF chemical substances Pregabalin (0408010AE), Gabapentin (0408010G0), Gabapentin (Neuropathic Pain) (0407030AD). 

##BNF Code 

The BNF Code is a 15 digit code in which the first seven digits are allocated according to the categories in the BNF and the last 8 digits represent the medicinal product, form, strength and the link to the generic equivalent product. NHS Prescription Services has created pseudo BNF chapters, which are not published, for items not included in BNF chapters 1 to 15. The majority of such items are dressings and appliances which NHS Prescription Services has classified into four pseudo BNF chapters (20 to 23). 

##Patient Identification  

Where patient identifiable figures have been reported they are based on the information captured during the prescription processing activities.  Please note, patient details cannot be captured from every prescription form and based on the criteria used for this analysis, patient information (NHS number) was only available for 98.34% of prescription items. 

The patient count figures are based on a distinct count of NHS number as captured from the prescription image. 

The figures for the number of identifiable patients should not be combined and reported at any other level than provided as this may result in the double counting of patients. For example, a single patient could appear in the results for multiple months. 

##Data Queries 

If you have any queries regarding the data provided, or if you plan on publishing, the data please contact foidata@nhsbsa.nhs.uk ensuring you quote the above reference. This is important to ensure that the figures are not misunderstood or misrepresented. 

##Reusing the data and copyright 

If you plan on producing a press or broadcast story based upon the data, please contact communicationsteam@nhsbsa.nhs.uk. This is important to ensure that the figures are not misunderstood or misrepresented. 

The information supplied to you continues to be protected by the Copyright, Designs and Patents Act 1988 and is subject to NHSBSA copyright. This information is licenced under the terms of the Open Government Licence detailed at: 

http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/  

Should you wish to re-use the information you must include the following statement: 

“NHSBSA Copyright 2024” This information is licenced under the terms of the Open Government Licence: 

http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/  

Failure to do so is a breach of the terms of the licence. 

Information you receive which is not subject to NHSBSA Copyright continues to be protected by the copyright of the person, or organisation, from which the information originated.  Please obtain their permission before reproducing any third party (non NHSBSA Copyright) information. 

Tags: gabapentin, pregabalin
Organization: Freedom of Information Disclosure Log